Caraco wins FDA OK for carbamazepine

New York, Dec. 12 - Caraco Pharmaceutical Laboratories, Ltd. said the Food and Drug Administration approved the company's ANDA for carbamazepine 200mg USP, the generic equivalent of Novartis' Tegretol.

The FDA also approved 100mg, 300mg and 400mg versions.

Tegretol is an anticonvulsant and used to treat pain associated with true trigeminal neuralgia.

Caraco Pharmaceutical is a Detroit-based maker of generic and private-label prescription pharmaceuticals.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.